Cargando…
Reduction of Plasma BCAAs following Roux-en-Y Gastric Bypass Surgery Is Primarily Mediated by FGF21
Type 2 diabetes (T2D) is a challenging health concern worldwide. A lifestyle intervention to treat T2D is difficult to adhere, and the effectiveness of approved medications such as metformin, thiazolidinediones (TZDs), and sulfonylureas are suboptimal. On the other hand, bariatric procedures such as...
Autores principales: | Shah, Harsh, Kramer, Alyssa, Mullins, Caitlyn A., Mattern, Marie, Gannaban, Ritchel B., Townsend, R. Leigh, Campagna, Shawn R., Morrison, Christopher D., Berthoud, Hans-Rudolf, Shin, Andrew C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10096671/ https://www.ncbi.nlm.nih.gov/pubmed/37049555 http://dx.doi.org/10.3390/nu15071713 |
Ejemplares similares
-
Acute Exposure to Branched-Chain Amino Acids (BCAAs) Impairs Glucose Homeostasis by Promoting Insulin Resistance in Mice
por: Gannaban, Ritchel, et al.
Publicado: (2022) -
Roux-en-Y gastric bypass surgery is effective in fibroblast growth factor-21 deficient mice
por: Morrison, Christopher D., et al.
Publicado: (2016) -
Roux-en-Y Gastric Bypass Surgery-Induced Weight Loss and Metabolic Improvements Are Similar in TGR5-Deficient and Wildtype Mice
por: Hao, Zheng, et al.
Publicado: (2018) -
Unlike calorie restriction, Roux-en-Y gastric bypass surgery does not increase hypothalamic AgRP and NPY in mice on a high-fat diet
por: Patkar, Presheet P., et al.
Publicado: (2019) -
Roux-en-Y gastric bypass surgery changes food reward in rats
por: Shin, Andrew C., et al.
Publicado: (2010)